6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tolerogenic dendritic cell therapy in organ transplantation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Although the occurrence of acute rejection was significantly reduced and the allograft survival at 1 year was massively improved by the development of pharmacological immunosuppressive drugs, little progress has been made regarding long-term graft survival. Cell therapy appears to be an innovative and promising strategy to minimize the use of immunosuppression in transplantation and consequently increases long-term graft survival. The strength of cell therapy is that it will induce graft-specific tolerance and not a general immunosuppression of the patients. Several candidates, such as tolerogenic dendritic cells, have been gaining interest as an efficient means of promoting antigen-specific tolerance over recent years. Studies performed in rodent models have demonstrated the feasibility and efficacy of tolerogenic dendritic cells for the induction of tolerance in transplantation. In parallel, protocols to generate human tolerogenic dendritic cells in vitro have been defined, and some phase I clinical trials in autoimmune diseases have been recently performed to evaluate the safety of tolerogenic dendritic cell therapy. In this review, we will focus on the potential therapeutic interest of these cells in transplantation as well as their generation and characterization in humans. Finally, we will describe our current clinical trial using autologous tolerogenic dendritic cells in transplantation.

          Related collections

          Author and article information

          Journal
          Transpl. Int.
          Transplant international : official journal of the European Society for Organ Transplantation
          Wiley-Blackwell
          1432-2277
          0934-0874
          Aug 2017
          : 30
          : 8
          Affiliations
          [1 ] INSERM UMR1064, Center for Research in Transplantation and Immunology, Nantes, France.
          [2 ] CHU de Nantes, Institut de Transplantation Urologie Nephrologie (ITUN), Nantes, France.
          [3 ] Université de Nantes, Nantes, France.
          Article
          10.1111/tri.12889
          27864897
          b055ae49-ea35-4c19-84a4-d3b5426ebd2e
          History

          autoimmune diseases,autologous tolerogenic dendritic cells,cell therapy,clinical trial,safety,transplantation

          Comments

          Comment on this article